His primary areas of investigation include Health policy, Environmental resource management, Developing country, Environmental health and Public economics. His study in Health policy is interdisciplinary in nature, drawing from both Global health, Program evaluation and Health promotion. His Global health study integrates concerns from other disciplines, such as Intensive care medicine, Disease burden and Drug resistance.
The Environmental resource management study combines topics in areas such as Political agenda, Intellectual property, Health law, Collective action and Economic policy. His Developing country research is multidisciplinary, incorporating perspectives in Psychological intervention and Right to health. His Public economics research is multidisciplinary, incorporating elements of Universal design, Low income and middle income countries, Corporate governance, Evidence-based practice and Antimicrobial use.
His primary areas of study are Global health, Health policy, Public economics, Public health and Health services research. His Global health study deals with the bigger picture of Economic growth. The various areas that John-Arne Røttingen examines in his Health policy study include Environmental resource management, Health administration, Public relations and Health promotion.
His work in Public economics tackles topics such as Developing country which are related to areas like Program evaluation. His Public health study incorporates themes from Private sector and Environmental health. John-Arne Røttingen has researched Environmental health in several fields, including Veterinary medicine and Epidemiology.
John-Arne Røttingen focuses on Public economics, Global health, Health policy, Economic growth and Incentive. His Public economics study combines topics in areas such as Developing country and Universal design. His study on Global health is covered under Health care.
The concepts of his Health policy study are interwoven with issues in International community, Environmental resource management and Health promotion. John-Arne Røttingen has included themes like Risk analysis and Immunology in his Outbreak study. His Life expectancy research integrates issues from Antimicrobial, Intensive care medicine, Disease burden and Drug resistance.
His main research concerns Public economics, Environmental resource management, Health policy, Developing country and Intensive care medicine. His biological study spans a wide range of topics, including Universal design and Economic growth, Gross domestic product. His work deals with themes such as Political agenda, Intellectual property, Health law, Collective action and Economic policy, which intersect with Environmental resource management.
His Health policy research is multidisciplinary, relying on both One Health, Evidence-based medicine, Program evaluation and Health promotion. His Developing country research incorporates elements of Psychological intervention and Regional policy. In Intensive care medicine, John-Arne Røttingen works on issues like Antimicrobial, which are connected to Life expectancy, Disease burden and Health care.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).
Ana Maria Henao-Restrepo;Anton Camacho;Ira M. Longini;Conall H. Watson.
The Lancet (2017)
A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known?
Røttingen Ja;Cameron Dw;Garnett Gp.
Sexually Transmitted Diseases (2001)
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
Ana Maria Henao-Restrepo;Ira M Longini;Matthias Egger;Matthias Egger;Natalie E Dean.
The Lancet (2015)
Access to effective antimicrobials: a worldwide challenge.
Ramanan Laxminarayan;Ramanan Laxminarayan;Precious Matsoso;Suraj Pant;Charles Brower.
The Lancet (2016)
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
Hongchao Pan;Richard Peto;Ana-Maria Henao-Restrepo.
The New England Journal of Medicine (2020)
Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?
John-Arne Røttingen;John-Arne Røttingen;Sadie Regmi;Mari Eide;Alison J Young.
The Lancet (2013)
Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004.
Piero L Olliaro;Piero L Olliaro;Philippe J Guerin;Sibylle Gerstl;Astrid Aga Haaskjold.
Lancet Infectious Diseases (2005)
Binding of human factor VIIa to tissue factor induces cytosolic Ca2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor.
John-Arne Røttingen;Tone Enden;Eric Camerer;Jens-Gustav Iversen.
Journal of Biological Chemistry (1995)
Coagulation Factors VIIa and Xa Induce Cell Signaling Leading to Up-regulation of the egr-1 Gene *
Eric Camerer;John-Arne Røttingen;Elisabet Gjernes;Kristin Larsen.
Journal of Biological Chemistry (1999)
Repurposed antiviral drugs for COVID-19: interim WHO solidarity trial results (Preprint)
Pan Hongchao;Richard Peto;Ana-Maria Henao-Restrepo;Marie-Pierre Preziosi.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: